More on Bladder Cancer
X
Univadis from Medscape
Video
Bladder cancer, although the fifth most common cancer in the United States, has remained at the starting line as other cancers charted record-breaking therapeutic progress for their patients. But Dr Seth Lerner and the multidisciplinary team from Baylor College of Medicine contend that bladder cancer is catching up. Innovations across diagnostic and therapeutic modalities are transforming bladder cancer management. Dr Lerner and his team report that dramatic changes in diagnostic staging, patient-tailored surgical approaches, less disfiguring reconstructive options, and a growing array of immunotherapies are fueling progress in the treatment of bladder cancer.
Show More
Comments